Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling

Published:2018-07 Issue: Volume:103 Page:435-442
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chen Wei,Wang Hui,Cheng Mei,Ni Ling,Zou Li,Yang Qin,Cai Xianghai,Jiao Baowei

Funder

Applied Basic Research Key Project of Yunnan

National Natural Science Foundation of China

Chinese Academy of Sciences

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference37 articles.

1. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study;Beiki;Breast Cancer Res.,2012

2. Triple-negative breast cancer: present challenges and new perspectives;Podo;Mol. Oncol.,2010

3. Triple-negative breast cancer: is there a treatment on the horizon?;Yao;Oncotarget,2017

4. Evaluation of treatment outcomes of triple-negative breast cancer;Cinkaya;J. Cancer Res. Ther.,2016

5. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol.,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoharringtonine induces apoptosis of mammary carcinoma cells by inhibiting the AKT/mTOR signaling pathway;Veterinary and Comparative Oncology;2023-12-11

2. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges;Seminars in Cancer Biology;2022-11

3. Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment;Cancer Cell International;2021-07-20

4. Ethnopharmacology, chemodiversity, and bioactivity of Cephalotaxus medicinal plants;Chinese Journal of Natural Medicines;2021-05

5. Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions;Journal of Medicinal Chemistry;2021-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3